FDA Warning Letter — Janssen Pharmaceuticals, dba Actelion Pharmaceutical

Case 42218 — FEI 3003498827

The FDA took a Warning Letter action against Janssen Pharmaceuticals, dba Actelion Pharmaceutical on November 24, 2008 (South San Francisco, CA). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.

Action Details

Facility
Janssen Pharmaceuticals, dba Actelion Pharmaceutical
Date
November 24, 2008
Fiscal Year
2009
Product Type
Drugs
Center
CDER
Location
South San Francisco, CA (United States)